Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1990 1
1993 1
1995 3
1999 1
2003 1
2006 1
2007 1
2008 3
2009 1
2010 2
2012 2
2013 3
2014 6
2015 1
2016 5
2017 4
2018 6
2019 2
2020 5
2021 3
2022 5
2023 5
2024 7
2025 4
2026 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

68 results

Results by year

Filters applied: . Clear all
Your search was processed without automatic term mapping because it retrieved zero results.
Page 1
Empagliflozin in Patients with Chronic Kidney Disease.
The EMPA-KIDNEY Collaborative Group; Herrington WG, Staplin N, Wanner C, Green JB, Hauske SJ, Emberson JR, Preiss D, Judge P, Mayne KJ, Ng SYA, Sammons E, Zhu D, Hill M, Stevens W, Wallendszus K, Brenner S, Cheung AK, Liu ZH, Li J, Hooi LS, Liu W, Kadowaki T, Nangaku M, Levin A, Cherney D, Maggioni AP, Pontremoli R, Deo R, Goto S, Rossello X, Tuttle KR, Steubl D, Petrini M, Massey D, Eilbracht J, Brueckmann M, Landray MJ, Baigent C, Haynes R. The EMPA-KIDNEY Collaborative Group, et al. N Engl J Med. 2023 Jan 12;388(2):117-127. doi: 10.1056/NEJMoa2204233. Epub 2022 Nov 4. N Engl J Med. 2023. PMID: 36331190 Free PMC article. Clinical Trial.
Frailty, Multimorbidity, and Polypharmacy: Exploratory Analyses of the Effects of Empagliflozin from the EMPA-KIDNEY Trial.
Mayne KJ, Sardell RJ, Staplin N, Judge PK, Zhu D, Sammons E, Cherney DZI, Cheung AK, Maggioni AP, Nangaku M, Rossello X, Tuttle KR, Ihara K, Iwata T, Wanner C, Emberson J, Preiss D, Landray MJ, Baigent C, Haynes R, Herrington WG; EMPA-KIDNEY Collaborative Group. Mayne KJ, et al. Clin J Am Soc Nephrol. 2024 Sep 1;19(9):1119-1129. doi: 10.2215/CJN.0000000000000498. Epub 2024 Jun 27. Clin J Am Soc Nephrol. 2024. PMID: 40179340 Free PMC article. Clinical Trial.
We derived a multivariable logistic regression model to predict hospitalization (reflecting frailty) and assessed empagliflozin's risk-benefit profile in a post hoc analysis of the double-blind, placebo-controlled EMPA-KIDNEY trial. ...
We derived a multivariable logistic regression model to predict hospitalization (reflecting frailty) and assessed empagliflozin's ris …
Two new species of Simulium (Gomphostilbia) (Diptera: Simuliidae) from peninsular Malaysia, with keys to 10 peninsular Malaysian species of the Simulium batoense species group.
Takaoka H, Sofian-Azirun M, Ya'Cob Z. Takaoka H, et al. J Med Entomol. 2014 Jan;51(1):10-26. doi: 10.1603/me13133. J Med Entomol. 2014. PMID: 24605448
S. (G.) azhari sp. nov. is characterized in the female by the narrow frons, and in the male by the broad style and the ventral plate moderately produced ventrally. S. (G.) johorense sp. nov. is also remarkable in having the female subcosta lacking hairs or be …
S. (G.) azhari sp. nov. is characterized in the female by the narrow frons, and in the male by the broad style and the ventral …
Clinicogenomic predictors of outcomes in patients with hepatocellular carcinoma treated with immunotherapy.
Cowzer D, Chou JF, Walch H, Keane F, Khalil D, Shia J, Do RKG, Yarmohammadi H, Erinjeri JP, El Dika I, Yaqubie A, Azhari H, Gambarin M, Hajj C, Crane C, Wei AC, Jarnagin W, Solit DB, Berger MF, O'Reilly EM, Schultz N, Chatila W, Capanu M, Abou-Alfa GK, Harding JJ. Cowzer D, et al. Oncologist. 2024 Oct 3;29(10):894-903. doi: 10.1093/oncolo/oyae110. Oncologist. 2024. PMID: 38937977 Free PMC article.
A Monte Carlo Study of Dynamic Phase Transitions Observed in the Kinetic S = 1 Ising Model on Nonregular Lattices.
Yüksel Y. Yüksel Y. Entropy (Basel). 2025 May 16;27(5):530. doi: 10.3390/e27050530. Entropy (Basel). 2025. PMID: 40422484 Free PMC article.
Benefiting from the recent results obtained for the thermodynamic phase transitions of the aforementioned lattice topologies [Azhari, M. and Yu, U., J. Stat. Mech. (2022) 033204], we explore the variation of the dynamic order parameter, dynamic scaling variance, and …
Benefiting from the recent results obtained for the thermodynamic phase transitions of the aforementioned lattice topologies [Azhari, …
68 results